Insmed Incorporated (INSM) Q1 2017 Earnings Results

Insmed Inc Misses on EPS, Stock Down 1.35%

Insmed Inc's earnings report showed a loss per share of $0.60, with no revenue figures disclosed. The stock reacted negatively, dropping 1.35%. Investors may be concerned about the lack of guidance and clarity on financial performance moving forward.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.60	N/A	N/A
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management acknowledged the challenges faced in the quarter. They emphasized the importance of their ongoing clinical trials but did not provide specific financial guidance.

Management did not provide specific revenue figures or guidance for the upcoming quarters.

The focus remains on advancing their clinical programs.

Insmed Inc Misses on EPS, Stock Down 1.35%

Key numbers

Management commentary

Insmed Incorporated

More earnings this week

Insmed Inc Misses on EPS, Stock Down 1.35%

Key numbers

Management commentary